Next |
home / stock / cmrx / cmrx message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CMRX News Article - Chimerix Reports Fourth Quarter and Year End 2022 Financial Result | whytestocks | investorshangout | 03/02/2023 4:00:47 PM |
whytestocks: $CMRX News Article - Chimerix Responds to Rubric Capital Management | whytestocks | investorshangout | 11/10/2022 9:36:04 PM |
whytestocks: $CMRX News Article - Rubric Capital Management Sends Letter to Chimerix Board of Direct | whytestocks | investorshangout | 11/10/2022 8:26:06 PM |
Thanks, saw that but neglected to post news. | kzivann | investorshub | 11/10/2022 7:09:19 PM |
https://www.businesswire.com/news/home/20221110005658/en/ | db7 | investorshub | 11/10/2022 4:48:23 PM |
More good news. | kzivann | investorshub | 11/03/2022 1:44:36 PM |
News looks good. | kzivann | investorshub | 09/26/2022 9:11:59 PM |
Nice news. Got some. | kzivann | investorshub | 08/29/2022 2:53:02 PM |
WEEEEEEEEE | weedtrader420 | investorshub | 08/08/2022 9:48:58 AM |
Monday fun here $CMRX$ WOW! Monkey pox vaccine | weedtrader420 | investorshub | 08/08/2022 2:49:36 AM |
$5 coming | weedtrader420 | investorshub | 08/04/2022 10:26:33 PM |
Looking good | mcjodie | investorshub | 08/04/2022 6:50:44 PM |
$CMRX$ | weedtrader420 | investorshub | 08/03/2022 2:48:23 PM |
from the $EBS earnings call transcript: | db7 | investorshub | 08/02/2022 1:37:32 PM |
my hope is that the BARDA negotiation is | db7 | investorshub | 08/01/2022 1:19:07 PM |
$CMRX$$$$$$$$ WOOHOOOOOO | weedtrader420 | investorshub | 08/01/2022 12:06:24 PM |
$CMRX$ $5 TARGET | weedtrader420 | investorshub | 07/29/2022 4:41:37 PM |
$CMRX$Surfin USA | weedtrader420 | investorshub | 07/26/2022 10:44:59 PM |
interesting if we get BARDA announcement this week; | db7 | investorshub | 07/26/2022 3:58:18 PM |
$CMRX - Nice news and nice pre market! | Trend22 | investorshub | 07/25/2022 12:00:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
– Dordaviprone (ONC201) ACTION Study Progressing; Reiterates Expectations for Interim Overall Survival (OS) Data in 2025 and Final OS Data in 2026 – – No Dose Limiting Toxicity in ONC206 Phase 1 Studies to Date, Preliminary Phase 1 Safety and Pharmacokinetic (PK) Data...